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Background
It has been hypothesized that neutralizing antibodies
(nAbs) should have broad specificity to be effective in
protection against diverse HIV-1 variants. The mother-
to-child transmission of HIV-1 is a model that provides
the opportunity to examine whether the breadth of
maternal nAbs would be associated with protection of
infants from infection.
Methods
Samples were obtained at delivery from 57 transmitting
mothers (T) matched with 57 non-transmitting mothers
(NT) enrolled in the multicenter French Perinatal Cohort
(ANRS EPF CO1) between 1990 and 1996. The mothers
did not receive antiretroviral therapy during pregnancy,
and did not breastfeed their infants. Sixty-eight (59.6%)
and 46 (40.4%) women were infected by B and non-B
viruses, respectively. Neutralization assays were carried
out in TZM-bl cells using a panel of 10 primary isolates of
6 clades (A, B, C, F, CRF01_AE, CRF02_AG) selected for
their moderate (tier 2) or low (tier 3) sensitivity to neutra-
lization. The presence and titers of Nab to each strain, and
the breadth of maternal nAbs at delivery were compared
between T and NT mothers.
Results
Although there was a trend for both higher frequency
and higher titers of nAbs in NT mothers vs T mothers
for almost all the primary isolates that were tested, the
differences were not statistically different when consider-
ing the entire population. However a few statistically sig-
nificant differences were observed with higher frequency
or higher titers of nAbs toward several individual strains
in NT mothers when analyzing separately the B-infected
or non-B infected mothers.
Conclusion
Our study confirms that the breadth of maternal nAbs is
not associated with protection of infants from infection.
However it suggests that, depending of the population,
some primary isolates could be indicators of nAbs asso-
ciated with a lower risk of MTCT.
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